Targeting Treatment-Resistant Breast Cancer Stem Cells with FKBPL and Its Peptide Derivative, AD-01, via the CD44 Pathway
暂无分享，去创建一个
E. O’Neill | R. Clarke | A. Kissenpfennig | H. McCarthy | H. Harrison | L. McClements | P. Jithesh | T. Robson | S. McIntosh | A. Papaspyropoulos | A. Yakkundi | H. McKeen | Matthew P. Ablett | Rachel Bennett | C. Donley | Hayley D. McKeen | R. Clarke